PTPA and familial pancreatic carcinoma: In that case, they further confirmed that NM combined with PP2A inhibitor significantly up-regulated phosphorylation of GSK-3β and promoted cellular apoptosis comparing to NM or PP2A alone, suggesting NM may improve the therapeutic outcomes of pancreatic cancer (38).